Diabetes therapy and cancer risk: Where do we stand when treating patients?

Grace E. Ching Sun; Sangeeta R. Kashyap; Christian Nasr

doi:10.3949/ccjm.81a.13140

Diabetes therapy and cancer risk: Where do we stand when treating patients?

Grace E. Ching Sun, DO
Grace E. Ching Sun
Department of Medicine, Section of Endocrinology & Metabolism, Assistant Professor of Medicine, Louisiana State University Health Sciences Center, Shreveport
DO
- Find this author on Google Scholar
- Find this author on PubMed
- Search for this author on this site
- For correspondence: [email protected]
Sangeeta R. Kashyap, MD
Sangeeta R. Kashyap
Endocrinology and Metabolism Institute, Cleveland Clinic; Associate Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
MD
and Christian Nasr, MD
Christian Nasr
Endocrinology and Metabolism Institute, Cleveland Clinic
MD

Cleveland Clinic Journal of Medicine
October 2014,
81
(10)
620-628;
DOI: https://doi.org/10.3949/ccjm.81a.13140

ABSTRACT

The pathophysiology of type 2 diabetes mellitus conveys increased cancer risk, and any antidiabetic drug may alter that risk in a favorable or unfavorable way. This article discusses the links between diabetes and cancer, the different agents available for treating diabetes, and the cancer risk associated with these therapies.

PDF

Previous Next

In this issue

Print
Download PDF
Article Alerts

Alerts for this Article

User Name *

Password *

Sign In to Email Alerts with your Email Address
Email *
Email Article

Email This Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.
Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following
Diabetes therapy and cancer risk: Where do we stand when treating patients?
Message Subject
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine

Message Body
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Citation Tools
Diabetes therapy and cancer risk: Where do we stand when treating patients?

Grace E. Ching Sun

Grace E. Ching Sun

Sangeeta R. Kashyap

Sangeeta R. Kashyap

and Christian Nasr

Christian Nasr

Cleveland Clinic Journal of Medicine

October 2014,

81

(10)

620-628;

DOI: 10.3949/ccjm.81a.13140

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Share
Share This Article
Diabetes therapy and cancer risk: Where do we stand when treating patients?

Grace E. Ching Sun

Grace E. Ching Sun

Sangeeta R. Kashyap

Sangeeta R. Kashyap

and Christian Nasr

Christian Nasr

Cleveland Clinic Journal of Medicine

October 2014,

81

(10)

620-628;

DOI: 10.3949/ccjm.81a.13140

Share This Article:
Post